[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hemophagocytic-lymphohistiocytosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":78,"states":79},"Hemophagocytic Lymphohistiocytosis",11,10,[8,16,23,30,36,42,48,54,59,65,71],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06160791","Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)",[12],"Phase 2","RECRUITING","2026-08-26T02:14:59.425132Z","2026-05-05T02:43:29.166290Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05306080","Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome",[20],"Early Phase 1","2026-08-26T02:15:45.413021Z","2026-05-05T02:35:31.628782Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06839456","Phase 1\u002F2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab\u002FCD19 Depleted HSCT",[27],"Phase 1\u002FPhase 2","2026-08-26T02:18:26.932189Z","2026-05-05T02:43:28.655842Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT02579967","Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies",[12],"2026-08-26T02:19:04.543908Z","2026-05-05T02:43:27.958949Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT04644016","Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders",[12],"2026-08-26T02:16:48.735701Z","2026-05-05T02:43:27.256850Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT05898477","Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis",[],"2026-08-26T02:15:50.539717Z","2026-05-13T02:55:06.392512Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT05277272","INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)",[],"2026-08-26T02:15:53.461103Z","2026-05-13T02:55:06.298103Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":46,"content_modified":58},"NCT05915208","Histiocytic Disorder Follow-up Study",[],"2026-05-13T02:55:06.394598Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT04528355","Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC",[],"2026-08-26T02:16:24.970704Z","2026-05-13T02:55:06.255132Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT01793168","Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.077983Z",{"nct_id":72,"title":73,"phases":74,"status":75,"updated_at":76,"content_modified":77},"NCT07660783","Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases",[12],"NOT_YET_RECRUITING","2026-08-26T02:17:16.980188Z","2026-07-05T03:45:20.258362Z",[],[80],{"state":81,"count":82,"slug":83},"Pennsylvania",3,"pennsylvania"]